Compare Vanguard Total Bond Market Index Fund ETF (BND) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Vanguard Total Bond Market Index Fund ETFTrade

Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Vanguard Total Bond Market Index Fund ETF vs Zimmer Biomet Holdings Inc — how do they compare? Vanguard Total Bond Market Index Fund ETF trades at $72.76, while Zimmer Biomet Holdings Inc trades at $91.23 (market cap $17.61B). The key difference: Zimmer Biomet Holdings Inc pays a 1.05% dividend while Vanguard Total Bond Market Index Fund ETF pays none, and Zimmer Biomet Holdings Inc is trading nearer its 52-week high, Vanguard Total Bond Market Index Fund ETF nearer its low. Which is the better fit depends on your goals.

	BND	ZBH
52-Week High	$75.17	$107.71
52-Week Low	$72.45	$79.58
Market Cap	—	$17.61B
Sector	—	Health
Enterprise Value	—	$24.66B
Dividend Yield	—	1.05%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vanguard Total Bond Market Index Fund ETF

No Aura AI signal available yet.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $94.08, up 3.0% in the past 24 hours, near its consensus price target of $97.67. The stock shows bullish technical signals with strong moving average support and has consistently beaten earnings estimates in recent quarters. Revenue grew to $8.23B in 2025, though net income margin declined to 8.56%. Recent corporate developments include expansion in Asia Pacific and a planned $1 billion share repurchase program in 2026.

ZBH presents a balanced outlook with steady revenue growth and shareholder returns via dividends and buybacks, but faces risks from margin compression and rising debt. Analyst sentiment is mixed with 40% buy ratings, suggesting moderate upside potential with caution around profitability trends and competitive pressures in the medical device sector.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BND

U.S. fixed income sees highest inflows since January amid rate, tech, and geopolitical concernsETF Trends · 1 day agoBullish View details →

ZBH

Zimmer Biomet names Chintan Desai president of Asia Pacific region, effective immediatelyPRNewsWire · 1 day agoBullish Zimmer Biomet schedules Q2 2026 earnings call for August 5 with webcast access.PRNewsWire · 2 days agoNeutral AI in orthopedic surgery market to hit $0.87B by 2030 with 27.2% CAGR, driven by tech advances and rising musculoskeletal disordersResearchandmarkets.Com · 4 days agoBullish View details →

About Vanguard Total Bond Market Index Fund ETF

This index measures the performance of a wide spectrum of public, investment-grade, taxable, fixed income securities in the US, including government, corporate, and international dollar-denominated bonds, as well as mortgage-backed and asset-backed securities-all with maturities of more than 1 year. All of the fund's investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the index.

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.